Fresh Equities
ASX:BLT

ASX:BLT

BENITEC BIOPHARMA LIMITED

BENITEC BIOPHARMA LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

1201/99 Mount St, North Sydney NSW 2060, Australia

Biotechnology
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors

Fresh Equities does not have BENITEC BIOPHARMA LIMITED directors data.


Announcements

All
All Time
  • Position on FIRB approval on 30 March 2020

    Takeover Announcements

  • Suspension from Official Quotation on 30 March 2020

    Stock Exchange Announcement

  • Trading Halt on 30 March 2020

    Stock Exchange Announcement

  • Pause in Trading on 30 March 2020

    Stock Exchange Announcement

  • Court approves re-domiciliation scheme on 30 March 2020

    Takeover Announcements

  • Change of Director's Interest Notice on 29 March 2020

    Shareholder Details

  • Results of Scheme Meeting on 26 March 2020

    Takeover Announcements

  • Chairperson's address and presentation for Scheme Meeting on 25 March 2020

    Takeover Announcements

    COVID-19 information relating to Scheme Meeting on 18 March 2020

    Takeover Announcements

  • Appendix 4D and Half Year Report on 26 February 2020

    Periodic Reports

  • Load More

News

Loading...